BRISTOL-MYERS SQUIBB's PARAPLATIN (CARBOPLATIN) DATA SUPPORT FIRST-LINE OVARIAN CANCER INDICATION DESPITE SURVIVAL PROFILE CONCERNS, FDA FINDS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".